Women | Men | Total PsA | Total PsA without RA code | Controls | |
N | 7565 | 4419 | 11 984 | 7612 | 119 840 |
A: Alimentary tract and metabolism | 60 | 51 | 57 | 53 | 31 |
Antidiabetics (A10) | 13 | 17 | 15 | 13 | 9.2 |
Drugs for peptic ulcer and gastro-oesophageal reflux disease (A02B) | 45 | 36 | 42 | 38 | 20 |
B: Blood and blood forming organs | 48 | 48 | 48 | 46 | 15 |
Folic acid (B03BB) | 35 | 34 | 35 | 34 | 0.5 |
C: Cardiovascular system | 63 | 61 | 62 | 59 | 48 |
Diuretics (C03) | 18 | 15 | 17 | 15 | 11 |
Beta blockers (C07) | 26 | 22 | 24 | 21 | 23 |
Calcium channel blockers (C08) | 18 | 19 | 19 | 18 | 12 |
ACE inhibitors (C09) | 46 | 50 | 47 | 45 | 34 |
Lipid reducer (C10) | 20 | 26 | 22 | 20 | 18 |
D: Dermatologicals | 44 | 45 | 44 | 45 | 16 |
Topical Antipsoriatics (D05A) | 15 | 19 | 16 | 19 | 0.7 |
Topical steroids (D07) | 28 | 26 | 27 | 28 | 9.5 |
G: Genito urinary system, sex hormones | 17 | 12 | 15 | 13 | 11 |
Estrogens (G03C) | 11 | 0 | – | 0.0 (male) 6.0 (female) | 0.0 (male) 8.6 (female) |
H: systemic hormonal preparations | 58 | 38 | 51 | 46 | 24 |
Glucocorticoids (H02AB) | 38 | 31 | 35 | 31 | 6.5 |
Thyroid gland (H03) | 33 | 10 | 25 | 23 | 18 |
J: Antiinfective for systemic use | 35 | 26 | 32 | 31 | 22 |
L: Antineoplastic, immunomodulating agents | 66 | 63 | 65 | 64 | 2.6 |
Immunosuppressants (L04) | 65 | 63 | 64 | 64 | 0.7 |
M: Musculoskeletal system | 82 | 79 | 81 | 79 | 30 |
NSAIDs (M01A) | 53 | 45 | 50 | 48 | 25 |
Gout medication (M04A) | 4.5 | 13 | 7.8 | 7.1 | 4.3 |
Bone mineralisation (M05B) | 7.4 | 1.5 | 5.3 | 3.9 | 1.8 |
N: Nervous system | 57 | 42 | 51 | 48 | 31 |
Analgesics (N02) | 43 | 31 | 39 | 35 | 19 |
Metamizol (N02BB02) | 33 | 23 | 29 | 27 | 15 |
Opioids (N02A) | 20 | 14 | 18 | 15 | 6 |
Psycholeptics (N05) | 9.2 | 6.1 | 8.1 | 7.8 | 6.6 |
Antidepressants (N06A) | 24 | 14 | 20 | 19 | 12 |
Antidementives (N06D) | 0.2 | 0.5 | 0.3 | 0.3 | 0.5 |
P: Antiparasitics, insecticides, repellents | 2.6 | 1.6 | 2.2 | 2.1 | 1.3 |
R: Respiratory system | 23 | 17 | 21 | 19 | 14 |
S: Sensory organs | 17 | 14 | 16 | 15 | 11 |
Ophtalmologicals (S01) | 15 | 12 | 14 | 13 | 10 |
V: Various | 5.2 | 5.2 | 5.2 | 4.6 | 3.4 |
Polypharmacy (≥5 medications at the same time), % | 52 | 45 | 49 | 45 | 17 |
Mean number of drugs with prescription of >30 DDDs at the same time (SD)* | 5.1 (2.8) | 4.7 (3.0) | 4.9 (2.8) | 4.6 (2.7) | 2.3 (2.5) |
Drugs are categorised by ATC groups.
*This is calculated for the month with the most prescribed drugs in 2021 for each individual.
ATC, Anatomical Therapeutic Chemical; DDDs, defined daily soses; NSAIDs, non-steroidal anti-inflammatory drugs; PsA, psoriatic arthritis.